Citius Pharmaceuticals
Stock Forecast, Prediction & Price Target
Citius Pharmaceuticals Financial Estimates
Citius Pharmaceuticals Revenue Estimates
Citius Pharmaceuticals EBITDA Estimates
Citius Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 | 9/30/2027 | 9/30/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $83.59M Low: $75.51M High: $91.67M avg. 0% | Avg: $200.00M Low: $180.67M High: $219.33M avg. 139.25% | Avg: $336.26M Low: $303.75M High: $368.76M avg. 68.12% | Avg: $438.05M Low: $395.71M High: $480.40M avg. 30.27% |
Net Income
% change YoY
| $-33.64M N/A | $-32.54M 3.26% | $-39.42M -21.15% | Avg: $3.97M Low: $-10.59M High: $13.61M avg. 110.08% | Avg: $97.43M Low: $63.49M High: $81.74M avg. 2350.14% | Avg: $143.72M Low: $125.67M High: $161.79M avg. 47.52% | Avg: $204.24M Low: $178.58M High: $229.91M avg. 42.10% |
EBITDA
% change YoY
| $-32.88M N/A | $-36.72M -11.69% | $0 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.23 N/A | -$0.23 0% | $0 100% | Avg: $0.01 Low: -$0.07 High: $0.09 avg. 0% | Avg: $0.48 Low: $0.42 High: $0.54 avg. 4699.99% | Avg: $0.95 Low: $0.83 High: $1.07 avg. 97.91% | Avg: $1.35 Low: $1.18 High: $1.52 avg. 42.10% |
Operating Expenses
% change YoY
| $33.31M N/A | $36.73M 10.25% | $41.99M 14.32% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Citius Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 637.46% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -10.59M, average is 3.97M and high is 13.61M.
What is Citius Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 59.41% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $75.51M, average is $83.59M and high is $91.67M.
What is Citius Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 1210.00% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.07, average is $0.01 and high is $0.09.